(Q39068084)

8 September 2017

title

Markers and function of human NK cells in normal and pathological conditions (English)

1 reference

8 September 2017

4

1 reference

8 September 2017

Genny Del Zotto

1

0 references

Daniela Pende

5

object named as

Daniela Pende

1 reference

8 September 2017

2

Emanuela Marcenaro

1 reference

8 September 2017

10

Alessandro Moretta

1 reference

8 September 2017

Mariella Della Chiesa

6

object named as

Mariella Della Chiesa

1 reference

8 September 2017

11

Lorenzo Moretta

1 reference

8 September 2017

Maria Cristina Mingari

9

object named as

Maria Cristina Mingari

1 reference

8 September 2017

Paola Vacca

3

1 reference

8 September 2017

Francesca Moretta

7

1 reference

8 September 2017

Tiziano Ingegnere

8

1 reference

8 September 2017

publication date

5 January 2017

1 reference

Cytometry Part B: Clinical Cytometry

8 September 2017

published in

1 reference

8 September 2017

volume

92

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

100-114

1 reference

Natural killer cells and dendritic cells: rendezvous in abused tissues

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human innate lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Innate lymphoid cells: new insights into function and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The biology of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The evolution of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Physical and functional association of LFA-1 with DNAM-1 adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Different checkpoints in human NK-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NK-CTLs, a novel HLA-E-restricted T-cell subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Signatures of human NK cell development and terminal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NK cells and type 1 innate lymphoid cells: partners in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Innate lymphoid cells--a proposal for uniform nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

MHC class I molecules and KIRs in human history, health and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human NK cell education by inhibitory receptors for MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Licensing of natural killer cells by host major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Early liaisons between cells of the innate immune system in inflamed peripheral tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Evolutionary struggles between NK cells and viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Roles of natural killer cells in antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Immune checkpoint blockade: a common denominator approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Features of Memory-Like and PD-1(+) Human NK Cell Subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NK cells recognize and kill human glioblastoma cells with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Effect of tumor cells and tumor microenvironment on NK-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Roles of regulatory T cells in cancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Diverse macrophages polarization in tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Natural killer cells in the treatment of high-risk acute leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

New approaches to graft engineering for haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Killer Ig–like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human NK cells: from surface receptors to the therapy of leukemias and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Advantages and applications of CAR-expressing natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

2B4 functions as a co-receptor in human NK cell activation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

NK cells: a lesson from mismatched hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

Dissecting CD56dim human NK cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21508

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.21508

1 reference

release_hrpezhop4ngsjntr76xogmphga

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hrpezhop4ngsjntr76xogmphga

24 November 2022

mapped directly with Wikidata item

1 reference